U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863571) titled 'Reduction of Edema with a Specialized Cocktail for Ultra-early Management in Ischemic Stroke' on March 03.
Brief Summary: Large ischemic stroke is a severe subtype of acute ischemic stroke (AIS), often leading to malignant cerebral edema, elevated intracranial pressure, and poor functional outcomes. Despite early aggressive treatment, malignant cerebral edema remains a major determinant of prognosis, even in cases of successful recanalization. Preclinical studies suggest that a pharmacological cocktail (PPA) may alleviate cerebral edema by modulating extracellular potassium balance, maintaining aquaporin-4 expression, and enhancing ...